Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128.

Saved in:
Bibliographic Details
Title: Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128.
Authors: Ortiz-Islas E; Laboratorio de Neurofarmacologia Molecular y Nanotecnologia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Montes P; Laboratorio de Neuroinmunoendocrinología, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Rodríguez-Pérez CE; Laboratorio de Neurofarmacologia Molecular y Nanotecnologia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Ruiz-Sánchez E; Laboratorio de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Sánchez-Barbosa T; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.; Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 07360, Mexico., Pichardo-Rojas D; Programa Prioritario de Epilepsia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Zavala-Tecuapetla C; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Carvajal-Aguilera K; Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, Mexico City 04530, Mexico., Campos-Peña V; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.
Source: Pharmaceutics [Pharmaceutics] 2025 Dec 18; Vol. 17 (12). Date of Electronic Publication: 2025 Dec 18.
Publication Type: Published Erratum
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41471143
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ortiz-Islas+E%22">Ortiz-Islas E</searchLink>; Laboratorio de Neurofarmacologia Molecular y Nanotecnologia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Montes+P%22">Montes P</searchLink>; Laboratorio de Neuroinmunoendocrinología, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Pérez+CE%22">Rodríguez-Pérez CE</searchLink>; Laboratorio de Neurofarmacologia Molecular y Nanotecnologia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Ruiz-Sánchez+E%22">Ruiz-Sánchez E</searchLink>; Laboratorio de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Sánchez-Barbosa+T%22">Sánchez-Barbosa T</searchLink>; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.; Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 07360, Mexico.<br /><searchLink fieldCode="AU" term="%22Pichardo-Rojas+D%22">Pichardo-Rojas D</searchLink>; Programa Prioritario de Epilepsia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Zavala-Tecuapetla+C%22">Zavala-Tecuapetla C</searchLink>; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Carvajal-Aguilera+K%22">Carvajal-Aguilera K</searchLink>; Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.<br /><searchLink fieldCode="AU" term="%22Campos-Peña+V%22">Campos-Peña V</searchLink>; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101534003%22">Pharmaceutics</searchLink> [Pharmaceutics] 2025 Dec 18; Vol. 17 (12). <i>Date of Electronic Publication: </i>2025 Dec 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101534003 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1999-4923 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219994923%22">19994923 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceutics <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41471143
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/pharmaceutics17121625
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ortiz-Islas E
      – PersonEntity:
          Name:
            NameFull: Montes P
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Pérez CE
      – PersonEntity:
          Name:
            NameFull: Ruiz-Sánchez E
      – PersonEntity:
          Name:
            NameFull: Sánchez-Barbosa T
      – PersonEntity:
          Name:
            NameFull: Pichardo-Rojas D
      – PersonEntity:
          Name:
            NameFull: Zavala-Tecuapetla C
      – PersonEntity:
          Name:
            NameFull: Carvajal-Aguilera K
      – PersonEntity:
          Name:
            NameFull: Campos-Peña V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 12
              Text: 2025 Dec 18
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1999-4923
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Pharmaceutics
              Type: main
ResultId 1